Evidence map›Paper›PMID 34585838›Full record

ArticleOrthopaedic surgery2021

Three-Dimensional Distribution of Bone-Resorption Lesions in Osteonecrosis of the Femoral Head Based on the Three-Pillar Classification.

Guang-Bo Liu, Qiang Lu, Hao-Ye Meng, Qi Quan, Yu-Xuan Zhang, Huo Li, Hai-Yang Ma, Jun Zhao, Peng Wang, Xue-Feng Zhou and 1 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Orthopaedic surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Guang-Bo LiuStrategic Support Force Medical Center, Beijing, China.ORCID https://orcid.org/0000-0002-0201-9165
Qiang LuDepartment of Orthopaedics, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
Hao-Ye MengDepartment of Orthopaedics, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
Qi QuanDepartment of Orthopaedics, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
Yu-Xuan ZhangDepartment of Orthopaedics, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
Huo LiDepartment of Orthopaedics, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
Hai-Yang MaDepartment of Orthopaedics, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
Jun ZhaoDepartment of Orthopaedics, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
Peng WangDepartment of Orthopaedics, the First Medical Center, Chinese PLA General Hospital, Beijing, China.
Xue-Feng ZhouStrategic Support Force Medical Center, Beijing, China.
Jiang PengDepartment of Orthopaedics, the First Medical Center, Chinese PLA General Hospital, Beijing, China.ORCID https://orcid.org/0000-0003-4662-9288
Chinese PLA General Hospital · CNAir Force General Hospital PLA · CNHealth First · US

Funding

National Natural Science Foundation of China 81972047
6 · The paper itself

Abstract

objectiveTo investigate three-dimensional distribution of bone-resorptive lesions based on the three-pillar classification and its effect on the disease progression of osteonecrosis of the femoral head (ONFH).

methodsA total of 194 femoral head CT images from 117 patients diagnosed with ARCO stage II and III ONFH were retrospectively reviewed from April 2014 to February 2019. Three-dimensional structures of the femoral head and the bone-resorptive lesions were reconstructed. Using the three-pillar classification and coronal plane of the femoral head, we divided each femoral head into six regions to observe the location characteristics of bone-resorption lesions, and explore the destruction of different areas of the femoral head by the bone-resorptive lesions. Then the hips were divided into two groups based on whether they contained bone-resorption lesions and compared the difference of stage II and stage III between the two groups.

resultsThe regional distribution revealed 39 (27.27%), 55 (38.46%), six (4.20%), 23 (16.08%), 17 (11.89%) and three (2.10%) bone-resorptive lesions in regions I, II, III, IV, V and VI respectively. The lateral pillar, AL (I + IV), contained 44.76% of the lesions, central pillar, C (II + V), 48.95%, and medial pillar, M (III + VI), 6.29%. Moreover, there were 81.82% bone-resorption lesions in anterolateral pillar, AL (I + II + IV), and 18.18% in posteromedial pillar, PM (III + V + VI). In all ONFH hips, the lateral pillar of 81(88.04%) femoral heads were affected, the central pillar of 84 (91.30%) femoral heads were affected, and the medical pillar of 29 (31.52%) femoral heads were affected. The ratio of ARCO stage III in the group with bone-resorption lesions was significantly higher than that of the group without bone-resorption lesions (76.09% vs 30.39%, P < 0.001).

conclusionsThis study demonstrated that the bone-resorption lesions are mainly distributed in the lateral and central pillar of the femoral head, and the two pillars of the femoral head are usually involved by bone-resorption lesions. Furthermore, the ratio of ARCO stage III in the group with bone-resorption lesions was significantly higher than that of the group without bone-resorption lesions, suggesting that the bone-resorption lesions might accelerate the progression of ONFH.

Indexed as

Tomography, X-Ray ComputedAdolescentAdultFemaleFemur Head NecrosisHumansMaleMiddle AgedRetrospective StudiesYoung AdultBone-resorptive lesionsCollapseOsteonecrosis of the femoral headThree-dimensional distributionThree-pillar classification

Identifiers

PMID34585838
PMCPMC8528984
OpenAlexW3201962401

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.